Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Clinical trial NCT07676331 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07676331
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-03-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.